Role of Pharmacists in Crohn’s Disease and Ulcerative Colitis Care
Inflammatory Bowel Disease (IBD), the two main forms being Crohn's disease and ulcerative colitis, is a chronic episodic disease where the body’s immune system attacks the gastrointestinal tract causing inflammation, open sores, scar buildup, nutrient malabsorption, anemia, chronic pain, and potentially life-threatening blockages and sepsis. Despite available treatments, IBD often progresses over time, and managing the disease becomes increasingly complex. A clash of genes, environment, diet, and the gut microbiome lead to IBD. Because it is multifactorial, there is no one-size-fits-all approach to treatment for people with Crohn’s and colitis.
A multidisciplinary approach is essential for effective IBD management. This involves collaboration amongst healthcare professionals—from gastroenterologists to dietitians—to create personalized treatment plans to address the disease’s complex nature. Each patient’s journey with IBD is unique, requiring tailored strategies that adapt to individual experiences and needs.
Given the complexity of Crohn’s and colitis, some patients need additional support with their treatments. This may include medication management advice, timely delivery of temperature-sensitive drugs, support with infusions and injections, assistance navigating multiple conditions, and access to trained nurses for education and support. Some pharmacists have developed a specialization and expanded their services to provide this level of care. Specialty pharmacies fulfill a vital role by offering these enhanced services to patients with advanced IBD, while other patients develop close partnerships with their local neighborhood pharmacies.
Crohn’s and Colitis Canada recognizes the important and distinct roles of both neighborhood and specialty pharmacies within the multidisciplinary care model. Central to this model is patient choice—offering individuals options to select the pharmacy that best meets their unique needs.